María G. Donday

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

María Chaparro, A Verreth, Triana Lobatón et al. · The American Journal of Gastroenterology · 2018 · 171 citations

Medicine, Immunology, Pediatrics +16

Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients

Adrián G. McNicholl, Alfredo J. Lucendo, Galina Fadeenko et al. · Clinical Gastroenterology and Hepatology · 2019 · 94 citations · Full text

Medicine, Infectious Diseases, Pharmacology +3

Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

María Chaparro, Manuel Barreiro‐de Acosta, Ana Echarri et al. · Digestive Diseases and Sciences · 2018 · 30 citations · Full text

Veterinary Medicine, Immunology, Pathology +16

The safety of drugs for inflammatory bowel disease during pregnancy and breastfeeding: the DUMBO registry study protocol of GETECCU

María Chaparro, María G. Donday, Francisco Abad‐Santos et al. · Therapeutic Advances in Gastroenterology · 2021 · 25 citations · Full text

Medicine, Obstetrics, Pharmacotherapy +17

EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain

María Chaparro, Manuel Barreiro‐de Acosta, J M Benítez et al. · Therapeutic Advances in Gastroenterology · 2019 · 22 citations · Full text

Public Health, Chronic Disease Control, Epidemiologic Methods +14